Orchestrating Global Decentralized Trials
Decentralized clinical trials (DCTs) leverage digital technologies, local diagnostic labs, and home nursing visits to bring clinical trial participation directly to patients globally.
Trial Efficiency
Decentralized protocols reduce patient drop-out rates by 38% while enabling trial sponsors to access diverse global demographic cohorts.
Key Trial Architecture Components
- eConsent & Digital Onboarding: Multi-lingual interactive consent modules with remote investigator verification.
- Direct-to-Patient Investigational Medicinal Products (IMP): Temperature-monitored logistics for trial medications.
- Real-World Telemetry: Continuous data ingestion via FDA-cleared wearable biometrics.